Correlation Between Valneva SE and Orgenesis
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Orgenesis, you can compare the effects of market volatilities on Valneva SE and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Orgenesis.
Diversification Opportunities for Valneva SE and Orgenesis
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Valneva and Orgenesis is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Valneva SE i.e., Valneva SE and Orgenesis go up and down completely randomly.
Pair Corralation between Valneva SE and Orgenesis
Given the investment horizon of 90 days Valneva SE ADR is expected to generate 0.36 times more return on investment than Orgenesis. However, Valneva SE ADR is 2.8 times less risky than Orgenesis. It trades about -0.08 of its potential returns per unit of risk. Orgenesis is currently generating about -0.03 per unit of risk. If you would invest 1,285 in Valneva SE ADR on August 31, 2024 and sell it today you would lose (880.00) from holding Valneva SE ADR or give up 68.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 92.78% |
| Values | Daily Returns |
Valneva SE ADR vs. Orgenesis
Performance |
| Timeline |
| Valneva SE ADR |
| Orgenesis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Valneva SE and Orgenesis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Orgenesis
The main advantage of trading using opposite Valneva SE and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.| Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
| Orgenesis vs. Tff Pharmaceuticals | Orgenesis vs. Quoin Pharmaceuticals Ltd | Orgenesis vs. Aerovate Therapeutics | Orgenesis vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |